Bioventus (BVS) Gross Profit (2020 - 2026)

Bioventus' Gross Profit history runs 7 years deep, the most recent figure standing at $90.8 million for Q1 2026.

• Quarterly Gross Profit rose 9.29% year-over-year to $90.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $395.9 million (up 3.39% YoY) and the FY2025 annual result came in at $388.2 million, changed 0.02% from the prior year.
• Gross Profit was $90.8 million for Q1 2026 at Bioventus, down from $108.8 million in the prior quarter.
• Across five years, Gross Profit topped out at $108.8 million in Q4 2025 and bottomed at $73.9 million in Q2 2023.
• A 5-year average of $89.8 million and a median of $89.1 million in 2023 frame the typical range for Gross Profit.
• Peak annual rise in Gross Profit reached 27.11% in 2022, while the deepest fall reached 15.47% in 2022.
• Bioventus' Gross Profit stood at $74.2 million in 2022, then advanced by 16.33% to $86.3 million in 2023, then advanced by 18.95% to $102.7 million in 2024, then grew by 5.97% to $108.8 million in 2025, then retreated by 16.56% to $90.8 million in 2026.
• Business Quant data shows BVS's Gross Profit at $90.8 million in Q1 2026, $108.8 million in Q4 2025, and $94.2 million in Q3 2025.